Healthcare Sales & Marketing Network News: antiviral

Searching News Database: antiviral

HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch

HSMN NewsFeed - 29 Nov 2021
Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Oct 2021
Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2021
Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Aug 2021
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Biopharmaceuticals

HSMN NewsFeed - 6 Jul 2021
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2021
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Aug 2020
ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jul 2020
FDA Clears Abivertinib for Phase 2 Safety and Efficacy Study in Hospitalized Patients with Moderate To Severe Covid-19
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2020
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
Biopharmaceuticals

HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2020
Viracta Receives Welcome FDA Guidance at Type C Meeting for the Treatment of EBV-Associated Lymphomas
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 30 Mar 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Biopharmaceuticals

HSMN NewsFeed - 26 Mar 2020
FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL(R) DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Feb 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Oct 2019
Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the Acucy(TM) Influenza A&B Test
Diagnostics FDA

HSMN NewsFeed - 4 Oct 2019
Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2019
Viracta Receives Orphan Drug Designation from the US FDA for its Lead Epigenetic Drug Candidate Nanatinostat for EBV-Associated Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Apr 2019
Arc Bio Unveils its Galileo(TM) Pathogen Solution: A Fully Integrated NGS-based Metagenomics Platform with a Revolutionized Design for Pathogen Detection
Diagnostics Product Launch

HSMN NewsFeed - 25 Feb 2019
Viriom Announces New CEO Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2018
Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 26 Jul 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
Diagnostics FDA Product Launch

HSMN NewsFeed - 27 Jun 2018
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Feb 2018
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2018
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2017
Viriom Announces New Director Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2017
Alere Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
Diagnostics FDA

HSMN NewsFeed - 23 Jun 2017
AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Jun 2017
Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2017
Regulus Announces Pipeline Updates and Advancements
Biopharmaceuticals

HSMN NewsFeed - 19 May 2017
Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS(R) (raltegravir) 600 mg in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Apr 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2017
FDA Approves Two Hepatitis C Drugs for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
Diagnostics FDA

HSMN NewsFeed - 16 Feb 2017
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
Diagnostics FDA

HSMN NewsFeed - 6 Jan 2017
Chimerix Appoints Randall Lanier, PhD as Chief Science Officer, and Roy W. Ware, PhD, MBA as Chief Manufacturing and Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2017
Ascletis Raises US$100 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Dec 2016
AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2016
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2016
Panther Biotechnology Receives Positive Feedback from the FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Aug 2016
Roche receives CLIA waiver for cobas(R) Influenza A/B & RSV test for the cobas(R) Liat(R)
Diagnostics FDA

HSMN NewsFeed - 26 Jul 2016
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR(TM) (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jun 2016
ContraVir Completes Merger with Ciclofilin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 17 May 2016
Agenovir Completes $10.6 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2016
AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2016
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA

HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Feb 2016
Cocrystal Pharma Announces In-Licensing of CRISPR Cas Technologies for Hepatitis B Virus and Human Papilloma Virus
Biopharmaceuticals Licensing

HSMN NewsFeed - 29 Jan 2016
Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Dec 2015
Enanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2015
Spring Bank Pharmaceuticals Names Nezam Afdhal, MD as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2015
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
Diagnostics FDA

HSMN NewsFeed - 28 Sep 2015
AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval in Japan for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Sep 2015
Ascletis Secures US$35 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Aug 2015
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jul 2015
Entasis Appoints Robin David Isaacs as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2015
Cidara Therapeutics Completes $42 Million Private Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Jan 2015
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2014
OnCore Biopharma Closes Series R Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Sep 2014
Chimerix Appoints W. Garrett Nichols, MD, MS as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Aug 2014
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2014
Gemmus Pharma Closes $3.3M Series B Funding to Develop Superior Flu Drug
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Apr 2014
Gilead’s Sovaldi(R) Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2014
Gilead Announces Results from Study of Sovaldi(R) for Retreatment of Chronic Hepatitis C in Patients Not Cured with Prior Antiviral Therapy
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2014
Alios BioPharma Raises $41 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Apr 2014
Chimerix Appoints Lisa Ricciardi to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2014
Novira Names Christian S. Schade Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2014
PTC Therapeutics Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2014
European Commission Grants Marketing Authorization for Gilead’s Sovaldi(R) (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Jan 2014
Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 6 Jan 2014
Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2013
Chimerix Appoints Linda M. Richardson as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2013
U.S. Food and Drug Administration Approves Gilead’s Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Nov 2013
3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as Vice President, Head of Global Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2013
Fred Cohen Appointed to BioCryst’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2013
3-V Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2013
Novira Therapeutics Completes $25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 14 Mar 2013
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2013
Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Nov 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Nov 2012
Biota Pharmaceuticals Announces Appointment of New Executive Officers
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2012
AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Oct 2012
XDx Appoints Peter Maag as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 10 Aug 2012
PharmAthene Receives FDA Notification On SparVax(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jul 2012
Idenix Pharmaceuticals Announces Restructuring of Development and Commercialization Collaboration With Novartis Pharma AG
Biopharmaceuticals

HSMN NewsFeed - 23 Jul 2012
Medline Acquires Parts of Personal Hygiene Business From Perrigo Company
Devices Acquisitions

HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA

HSMN NewsFeed - 20 Dec 2011
Todd R. Nelson Ph.D. Named President & Chief Executive Officer of MP Biomedicals
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2011
TOPICA Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2011
PharmAthene Appoints Linda L. Chang Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals

HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 18 May 2011
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
Diagnostics FDA

HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 1 Mar 2011
Paloma Pharmaceuticals Update on Ocular Clinical and Oncology Programs
Biopharmaceuticals Ophthalmology Oncology

HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 7 Feb 2011
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Oct 2010
Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel

HSMN NewsFeed - 4 Oct 2010
New American Therapeutics Acquires Antiviral Drug Denavir(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 29 Sep 2010
Tobira Therapeutics Inc. Raises $31 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Sep 2010
Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Diagnostics FDA

HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2010
Cytheris Closes 12 Million ($15 Million) Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2010
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2010
AVI BioPharma Appoints David Boyle Interim President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2010
Idera Pharmaceuticals Announces Management Appointments and Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Mar 2010
Ambrilia Biopharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2010
AVI BioPharma Announces Pending Changes to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2010
Medivir partners with Meda to commercialize Xerese(TM) (Lipsovir(R)) in North America
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2010
Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 Feb 2010
Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jan 2010
Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Oct 2009
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Diagnostics FDA

HSMN NewsFeed - 8 Oct 2009
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 16 Sep 2009
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 15 Sep 2009
European Union Commission Approves Expanded Use of ISENTRESS(R) (raltegravir), from MSD, in Adult Patients with HIV-1 Infection
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2009
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Aug 2009
Chimerix Raises $16.1 Million in Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Aug 2009
Dr. Nathaniel Brown Joins Presidio Pharmaceuticals, Inc. as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2009
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2009
Alios BioPharma, Inc. Closes $32 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS

HSMN NewsFeed - 20 Apr 2009
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2009
Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS

HSMN NewsFeed - 26 Feb 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Feb 2009
AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2009
Alios BioPharma, Inc. Completes First Closing of Series A Financing With Commitment of $24 MM From 3 Top-Tier Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Feb 2009
AVI BioPharma, Inc. Appoints Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2009
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 6 Feb 2009
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
Biopharmaceuticals Licensing HIV/AIDS

HSMN NewsFeed - 26 Jan 2009
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 21 Jan 2009
Panacos Announces Sale of Bevirimat
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 3 Dec 2008
AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Nov 2008
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2008
Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 29 Oct 2008
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 Sep 2008
Amarin Appoints Dr. Paresh Soni as SVP and Head of Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Aug 2008
INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
Biopharmaceuticals HIV/AIDS Regulatory

HSMN NewsFeed - 29 Aug 2008
Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
Biopharmaceuticals

HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jun 2008
Tobira Therapeutics Inc. Announces Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jun 2008
Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 16 Jun 2008
GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Apr 2008
New York Medicaid Program Establishes Coverage for Trofile(TM)
Diagnostics Biopharmaceuticals HIV/AIDS Reimbursement

HSMN NewsFeed - 25 Mar 2008
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Mar 2008
Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Mar 2008
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Mar 2008
Roche Statement Regarding Tamiflu U.S. Label Revision
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Feb 2008
Siemens Receives FDA Approval for the VERSANT 440 Molecular System
Diagnostics FDA

HSMN NewsFeed - 13 Feb 2008
VLST Corporation Announces Board and Executive Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2008
Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2008
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2008
The Aethlon Hemopurifier(R) Proves Effective in Capturing Bird Flu Virus
Devices

HSMN NewsFeed - 21 Jan 2008
FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Biopharmaceuticals FDA HIV/AIDS

HSMN NewsFeed - 19 Jan 2008
FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 7 Jan 2008
Panacos Appoints Jane Pritchett Henderson Chief Financial and Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2008
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2007
Cubist Pharmaceuticals Acquires Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Dec 2007
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 20 Dec 2007
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 17 Dec 2007
Immusol Changes Name to ItherX, Names Jeffrey F. McKelvy President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
Meridian Bioscience Receives FDA Clearance for Two New Rapid Tests for the Detection of Influenza and Respiratory Syncytial Virus
Diagnostics FDA

HSMN NewsFeed - 12 Nov 2007
ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Nov 2007
Gilead Announces 48-Week Data from Two Pivotal Phase III Studies Evaluating Viread(R) For the Treatment of Chronic Hepatitis B
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2007
Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2007
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Biopharmacetuicals

HSMN NewsFeed - 2 Nov 2007
First Studies Demonstrating Greater than Sixty Percent Sustained Viral Response Rates with Half the Standard Treatment Duration in Genotype 1 Chronic Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Aethlon Medical Initiates Human Clinical Studies
Devices

HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2007
AVI BioPharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2007
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 24 Oct 2007
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2007
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Oct 2007
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
Biopharmaceuticals

HSMN NewsFeed - 8 Oct 2007
Use of Quidel QuickVue(R) Rapid Flu Test in Nursing Homes Allows for More Rapid Recognition of Outbreaks and Appropriate Therapies
Diagnostics

HSMN NewsFeed - 5 Oct 2007
Teva Announces Tentative Approval of Generic Valtrex(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Sep 2007
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
Diagnostics

HSMN NewsFeed - 24 Sep 2007
Panacos Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 20 Sep 2007
Shareholders Approve Inhibitex Acquisition of FermaVir
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2007
New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 18 Sep 2007
Presidio Pharmaceuticals Adds Industry Veteran Dr. Richard Colonno as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
FDA Advisory Committee Unanimously Recommends Accelerated Approval of ISENTRESS(TM) (raltegravir), Merck's Investigational Oral Integrase Inhibitor, for Treatment of HIV
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 29 Aug 2007
Presidio Pharmaceuticals Closes $26 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Aug 2007
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Biopharmaceuticals

HSMN NewsFeed - 10 Aug 2007
Pacific Beach BioSciences and Dong Wha Pharmaceuticals Sign Exclusive License Agreement to Develop and Commercialize Zabofloxacin (PB-101, DW-224a)
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Aug 2007
Monogram Announces Commercial Introduction of Trofile(TM) Assay
Diagnostics HIV/AIDS

HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel

HSMN NewsFeed - 20 Jul 2007
Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 20 Jul 2007
European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 17 Jul 2007
Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
Diagnostics Licensing

HSMN NewsFeed - 13 Jul 2007
Valopicitabine Development Program Placed on Clinical Hold in the United States
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2007
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2007
APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease Announces Completion of Patient Enrollment
Devices Drug Delivery Interventional Cardiology

HSMN NewsFeed - 6 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 6 Jul 2007
TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 5 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jun 2007
Serenex Secures $31 Million in Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Jun 2007
Koronis Pharmaceuticals Raises $20 Million
Biopharmaceuticals HIV/AIDS Venture Capital

HSMN NewsFeed - 27 Jun 2007
Cyclacel Pharmaceuticals Announces Appointment of Distinguished Pharma Executive as Senior Vice President, Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jun 2007
Naryx Pharma, Inc. Announces the Appointment of Andy H. Strayer, Pharm.D. as Vice President of Clinical Operations and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2007
Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2007
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Diagnostics Regulatory

HSMN NewsFeed - 14 Jun 2007
Critical Biologics Appoints Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2007
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 11 Jun 2007
Response Biomedical Files for US FDA 510(k) Market Clearance of Rapid Influenza A+B Test
Diagnostics FDA

HSMN NewsFeed - 11 Jun 2007
Pivotal Phase III Trial Showed PROMACTA(R) (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jun 2007
Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon(R)
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2007
Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 21 May 2007
BARACLUDE(R) (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
Biopharmaceuticals

HSMN NewsFeed - 10 May 2007
Cortex and the University of Alberta Complete Patent License Agreement
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 30 Apr 2007
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Apr 2007
SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 24 Apr 2007
FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 19 Apr 2007
Xechem Receives $7 Million from New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Apr 2007
Panacos Announces New Board Member
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2007
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
BioDelivery Sciences Names Al Medwar as Vice President of Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2007
Brian M. Gallagher Joins Transport Pharmaceuticals' Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Apr 2007
Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Apr 2007
PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Mar 2007
AVI BioPharma Chairman and CEO Resigns
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Mar 2007
Cepheid Introduces CE Mark Certified Smart HBV(TM) Test for SmartCycler(R) System
Diagnostics Regulatory

HSMN NewsFeed - 14 Mar 2007
Valeant Pharmaceuticals Initiates Taribavirin Phase 2b Clinical Study
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2007
Roche Files Supplemental New Drug Application with U.S. Food & Drug Administration for Tamiflu(R) 30 mg and 45 mg Capsules
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2007
Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect
Diagnostics FDA

HSMN NewsFeed - 2 Mar 2007
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
Biopharmacetuicals Regulatory

HSMN NewsFeed - 1 Mar 2007
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 28 Feb 2007
Hana Biosciences Appoints Lyn Wiesinger to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Feb 2007
Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon(R) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2007
Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2007
ViroPharma Receives Orphan Drug Designation for Maribavir for Cytomegalovirus Viremia and Disease Indication
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2007
Valtrex (valacyclovir) - US Patent Litigation Update
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Jan 2007
Virabiotic's MolluscuDerm(TM) Topical Antiviral Therapy Launches at American Academy of Dermatology Meeting Feb. 2-5, 2007
Biopharmaceuticals Dermatology

HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
Pharmasset Appoints Michelle Berrey as Chief Medical Officer and William Symonds as Vice President, Clinical Pharmacology
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
John Z. Sullivan-Bolyai, M.D., MPH, Joins Anadys Pharmaceuticals as Vice President, Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2007
AVI BioPharma and Eleos Announce Cross-License Agreement for p53 Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Jan 2007
Panacos Appoints Alan W. Dunton, M.D. as New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
Diagnostics Regulatory

HSMN NewsFeed - 8 Jan 2007
Progenics Pharmaceuticals Expands Senior Management Team and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Dec 2006
SciClone and Sigma-Tau Complete Enrollment in Phase 3 Triple Therapy Hepatitis C Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 22 Dec 2006
Company Announces Acquisition of Research and Development Programs, Hiring of Senior Management Team and Name Change
Biopharmaceuticals Acquisitions Personnel

HSMN NewsFeed - 20 Dec 2006
FDA Approves Orphan Drug Designation for SIGA's Smallpox Drug, SIGA-246
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Dec 2006
Valeant Pharmaceuticals and Metabasis Therapeutics License Rights to Hepatitis B Compound Pradefovir to Schering-Plough Corporation
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Dec 2006
Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral Hepatitis B Treatment In Development With Valeant Pharmaceuticals and Metabasis Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Dec 2006
Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Nov 2006
Genentech Announces Agreement to Acquire Tanox for $20 Per Share
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Nov 2006
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2006
Human Genome Sciences Reports Positive Interim Results of Phase 2 Trials of Albuferon(TM) With Ribavirin in Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 30 Oct 2006
BARACLUDE(R) (Entecavir) Demonstrated Viral Suppression to Undetectable Levels in Most Patients in a Three-Year Cohort
Biopharmaceuticals

HSMN NewsFeed - 30 Oct 2006
Study Shows Treatment with BARACLUDE(R) (Entecavir) Resulted in Greater Viral Load Reductions Compared to Adefovir in Antiviral Naive Chronic Hepatitis B E-Antigen Positive Patients
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Idenix Announces New 24-Week Data From A Phase IIb Clinical Trial Of Valopicitabine Plus Pegylated Interferon in Treatment Naive Genotype-1 Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Roche Oral Polymerase Inhibitor R1626 Shows Strong Antiviral Activity in Chronic Hepatitis C Patients in Early Trial
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Royalty Pharma Announces Agreement Regarding the Purchase of the Rights to a Pre-Existing Royalty Interest in HUMIRA(R) From AstraZeneca and CAT
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Oct 2006
Roche Advances Oral Polymerase Inhibitor into Phase II Study in Patients with Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 9 Oct 2006
Diatos Strengthens Management Team with the Appointment of New Chief Medical Officer and New Chief Sales & Marketing Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Oct 2006
Human Genome Sciences Reports Significant Progress and Outlines Its Next Steps on the Path to Commercialization
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2006
Human Genome Sciences Announces Phase 3 Clinical Development Program for Albuferon(TM) in Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2006
Viral Suppression in Triple-Class Drug Resistant Patients Maintained after 24 Weeks of Treatment with MK-0518, an Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT)
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 29 Sep 2006
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2006
GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2006
GSK Grants License for Manufacture of Influenza Treatment Zanamivir
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Sep 2006
Tibotec Therapeutics Announces Initiation of the Largest U.S. Clinical Study Examining HIV Treatment in Treatment-Experienced Adult Women
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 11 Jul 2006
Panacos Announces Promotion of Graham P. Allaway, Ph.D. to President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2006
Cardinal Health Signs Agreement With Roche to Manufacture Tamiflu(R)
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2006
Jonathan R. Spicehandler, M.D. Retires From Schering-Plough
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2006
Vertex Pharmaceuticals and Janssen Pharmaceutica, a Johnson & Johnson Company, Form Collaboration to Develop and Commercialize VX-950 for Treatment of Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Jun 2006
New Data Show FUZEON(R) Continues to Provide Significant Immune System Benefits in Patients Despite Ongoing Viral Replication
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2006
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2006
96-Week Viral Suppression Data From Two Studies Presented for BARACLUDE(R) (entecavir) in Chronically-Infected Hepatitis B Patients
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
Researchers Report Results for 28-day Phase II Study of VX-950 in Combination with Pegylated Interferon and Ribavirin in Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
Panacos Appoints Dr. Frederick Schmid Senior Vice President, Commercial Operations and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2006
Pfizer to Invest $25 Million in Monogram
Diagnostics Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 8 May 2006
Pfizer and Monogram to Make HIV Co-Receptor Tropism Assay Available Globally
Diagnostics Biopharmaceuticals HIV/AIDS

Return to NewsFeed

Additional items found! 362

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 362 additional stories matching:
antiviral
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.